Status:
UNKNOWN
Electronic Medical Record Alerts to Optimize Medical Therapy in Heart Failure and Reduced Ejection Fraction
Lead Sponsor:
Instituto Cardiovascular de Buenos Aires
Conditions:
HFrEF - Heart Failure With Reduced Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized...
Eligibility Criteria
Inclusion
- Patients
- Eligible patients will include those with an EF ≤ 40% on their most recent echocardiogram, age \> 18, and an outpatient cardiology encounter during the study period.
- Age 18 or over
Exclusion
- under optimal medical treatment
- palliative care, or undergoing hemodialysis will be excluded
- Cardiologist
- Inclusion criteria:
- Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.
- Exclusion criteria Cardiologists belonging to the heart failure service
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06166823
Start Date
January 15 2024
End Date
January 1 2025
Last Update
December 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.